Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:26 am Purchase | 2025-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 4,599,860 8.200% | 1,170,313 (+34.12%) | Filing History |
| 2026-02-13 3:58 pm Purchase | 2025-12-31 | 13G | Repligen Corporation RGEN | Roy T. Eddleman Living Trust | 2,705,689 4.810% | 2,705,689 (New Position) | Filing History |
| 2026-02-05 1:36 pm Purchase | 2025-12-31 | 13G | Repligen Corporation RGEN | FMR LLC | 2,891,140 5.100% | 1,593,180 (+122.74%) | Filing History |
| 2025-09-08 1:35 pm Sale | 2025-08-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 3,429,547 6.100% | -3,706,539 (-51.94%) | Filing History |
| 2025-04-24 09:52 am Sale | 2025-03-31 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 5,198,107 9.300% | -1,909,417 (-26.86%) | Filing History |
| 2025-02-14 09:44 am Purchase | 2024-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 7,136,086 12.700% | 743,841 (+11.64%) | Filing History |
| 2025-02-13 11:20 am Unchanged | 2024-12-31 | 13G | Repligen Corporation RGEN | Roy T. Eddleman Living Trust | 2,705,689 4.840% | 0 (Unchanged) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 6,392,245 11.400% | 273,275 (+4.47%) | Filing History |
| 2024-11-12 11:44 am Unchanged | 2024-09-30 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 7,107,524 12.700% | 0 (Unchanged) | Filing History |
| 2024-10-23 5:04 pm Sale | 2024-09-30 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 7,107,524 12.700% | -752,006 (-9.57%) | Filing History |
| 2024-09-10 5:08 pm Purchase | 2024-08-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 6,118,970 10.900% | 2,106,119 (+52.48%) | Filing History |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 4,012,851 7.200% | -1,057,806 (-20.86%) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Repligen Corporation RGEN | The Vanguard Group | 5,078,261 9.100% | -126,894 (-2.44%) | Filing History |
| 2024-02-06 1:41 pm Unchanged | 2023-12-31 | 13G | Repligen Corporation RGEN | Roy T. Eddleman Living Trust | 2,705,689 4.850% | 0 (Unchanged) | Filing History |
| 2024-01-23 11:52 am Purchase | 2023-12-31 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 7,859,530 14.100% | 1,735,936 (+28.35%) | Filing History |
| 2023-02-15 5:22 pm Sale | 2022-12-31 | 13G | Repligen Corporation RGEN | Roy T. Eddleman Living Trust | 2,705,689 4.870% | -794,311 (-22.69%) | Filing History |
| 2023-02-14 12:37 pm Purchase | 2022-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 5,070,657 9.100% | 2,028,002 (+66.65%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Repligen Corporation RGEN | The Vanguard Group | 5,205,155 9.370% | 292,386 (+5.95%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 6,123,594 11.000% | 436,597 (+7.68%) | Filing History |
| 2022-09-08 1:43 pm Purchase | 2022-08-31 | 13G | Repligen Corporation RGEN | BlackRock Inc. BLK | 5,686,997 10.200% | 497,808 (+9.59%) | Filing History |